Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

PRESS RELEASE October 28, 2021 Mentice publishes the company’s interim report for the period January–September 2021

Continued growth through Q3 and for the year to date  Third quarter (July–September 2021) and the first nine months of the year (January-September 2021) · Order intake amounted to 51.8 (34.6) MSEK for the third quarter and 131.9(95.5) MSEK for the first nine months of the year. · Order book by the end of the period was 83.6 (43.0) MSEK. · Net sales amounted to 38.7 (33.4) MSEK for the third quarter and 117.4(91.6) MSEK for the first nine months of the year. · Earnings before depreciations and amortisations (EBITDA) totaled -0.6(4.1) MSEK for the third quarter

IRRAS Accounces Announces First Patient Enrolled in ARCH Study, a Comparative Clinical Trial Designed to Confirm IRRAflow’s Ability to Improve Clearance of Clot after IVH

· Dr. Behnam Rezai Jahromi (Neurosurgeon) and Dr. Jari Siironen (Head of Neurosurgical ICU) from Helsinki University Hospital successfully enrolled the first patient in the ARCH (Active Removal of IntraCerebral Hematoma via active irrigation of ventricular system) clinical trial. · ARCH is designed to compare the ability of IRRAS’ IRRAflow system to traditional ventricular drainage in the clearance of blood after an intraventricular hemorrhage (IVH).   · The ARCH study investigators hypothesize that the addition of thrombolytic medication to IRRAflow’s active irrigation will reduce the

Klaria Interim Report Q3 2021

Summary of the interim reportPromising quarter with registration applications and preparations for additional clinical studies THIRD QUARTER OF 2021 · Net sales amounted to 0.0 MSEK (0.0 MSEK) · Other income amounted to 0.0 MSEK (3.4 MSEK) · R&D costs for the period amounted to 12.5 MSEK (13.6 MSEK) · Profit after tax amounted to -15.2 MSEK (-13.3 MSEK) · Earnings per share for the quarter amounted to -0.29 SEK (-0.28 SEK) · Cash flow from operating activities amounted to -13.7 MSEK (-12.2 MSEK) · Cash and cash equivalents on the balance sheet date amounted to 25.9

Mandatory notification of trade

Anooj Unarket, Board member of Otello Corporation ASA, has on behalf of certain related parties, as of 27th October 2021, acquired interests in shares of Otello Corporation ASA. The balance of Anooj Unarket and related parties’ holdings after the transaction totals 26,106,695 shares. Please refer to the attached notification of trading for further details. This information is subject to disclosure requirements in regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

Immunovia receives Presidential Poster Award at the American College of Gastroenterology Annual Scientific Meeting

LUND, SWEDEN – Immunovia AB (publ) (“Immunovia”), a diagnostic company that develops and sells highly accurate blood tests for the early detection of cancer, today announced that Thomas King, MD, PhD, Medical Director of Immunovia, Inc. was awarded the Presidential Poster Award at the American College of Gastroenterology (ACG) Annual Scientific Meeting for the pivotal blind validation results for the IMMray™ PanCan-d test.   The abstract reports the results of Immunovia, Inc.’s blind validation study, demonstrating that the IMMray™ PanCan-d test can identify stage I & II pancreatic

Update on regulatory approvals relating to the voluntary tender offer for Sbanken ASA – Extension of Drop Dead Date

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, INTO OR WITHIN CANADA, AUSTRALIA, NEW ZEALAND, SOUTH AFRICA, HONG KONG, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL Oslo, 28 October 2021 Reference is made to the offer document dated 23 April 2021 (the "Offer Document") and subsequent stock exchange announcements, including 24 May 2021 (extension of the Offer Period until 7 June 2021), 7 June 2021 (final extension of Offer Period until 14 June 2021, reduction of minimum acceptance condition to 2/3 and

Ahlstrom-Munksjö expands its Reliance® portfolio to now include its historical Dextex range of wetlaid nonwoven sterilization wraps

AHLSTROM-MUNKSJÖ OYJ PRESS RELEASE OCTOBER 28, 2021 at 9:25 (EEST) Ahlstrom-Munksjö's sterile barrier systems offer excellent bacterial barrier thanks to cellulosic fibers that create a tortuous path for excellent sterility maintenance of surgical instruments up to the point of use. Thanks to their features, our high-performance sterilization wraps play a key role in the prevention of hospital-acquired infections, protecting patients’ health. Dextex wetlaid sterilization wraps have a long history of use in the sterilization industry and are well recognized throughout the globe for

Sectra to highlight brilliant radiology workflows at RSNA 2021

Linköping, Sweden and Shelton, CT – October 28, 2021 – “Brilliant workflows. Made for you.” is the key theme for international medical imaging IT and cybersecurity company Sectra  (STO: SECT B) in booth #8115 at the Radiological Society of North America (RSNA) 2021 Annual Meeting. The company will showcase its complete enterprise imaging offering and latest innovations for enhancing workflows to help tackle the growing workloads in radiology.The radiology community has taken one of its biggest hits in history with the

Interim Report Q2 1 April - 30 September 2021

Second quarter (1 July - 30 September 2021) · Net sales increased by 20 percent and amounted to SEK 3,257 million (2,723). · Operating profit before amortisation of intangible non-current assets (EBITA) increased by 39 percent and amounted to SEK 425 million (306) corresponding to an EBITA margin of 13.1 percent (11.2).  · Operating profit increased by 45 percent and amounted to SEK 351 million (242) corresponding to an operating margin of 10.8 percent (8.9). · Profit after tax increased by 45 percent and amounted to SEK 263 million (181) and earnings per share before/after

Terveystalo financial calendar and AGM in 2022

Terveystalo Plc Stock Exchange Release 28 October 2021 at 09:05 EEST In 2022, Terveystalo Plc will publish financial reports as follows: · Financial Statements Bulletin 2021 on Thursday, 10 February 2022 · Annual Report (incl. Corporate Responsibility) 2021 on week 7, 2022 · Interim report for January-March 2022 on Thursday, 28 April 2022 · Half-Year Report for January-June 2022 on Tuesday, 19 July 2022 · Interim report for January-September 2022 on Thursday, 27 October 2022 The Financial Statements Bulletin 2021 and financial reviews for 2022 will be published at

Alzinova AB interim report January – September 2021

The Board of Directors and the Chief Executive Officer of Alzinova AB hereby present the interim report for the period January –September 2021.Nine months, January – September 2021 · Net sales amounted to 0 SEK (0 SEK). · Result after financial items amounted to -5,096,381 SEK ( -4,138,472 SEK). · Earnings per share amounted to -0.32 SEK (-0.54 SEK). · Equity ratio amounted to 96.6% (94.4%). Three months, July – September 2021 · Net sales amounted to 0 SEK (0 SEK). · Result after financial items amounted to -1,455,142 SEK ( -1,240,085 SEK). · Earnings per share

Exel Composites publishes its Q1-Q3 2021 Business Review on 4 November 2021

EXEL COMPOSITES PLC      INVESTOR NEWS      28 OCTOBER 2021 at 09:00 EETExel Composites publishes its Q1-Q3 2021 Business Review on Thursday 4 November 2021 at approximately 09:00 EET. A financial results briefing for investors, analysts and journalists will be held the same day at 12:30 EET. The briefing will be hosted by Riku Kytömäki, President and CEO. The briefing will be organized online. Participants are requested to register to the event in advance by sending an email to investor@exelcomposites.com no later than by Wednesday 3 November 2021 at 10:00 EET. A link to join the event

Interim Report January – September 2021: With sights set on the future

Catena’s strong development continues. Stable cash flows and profit from property management that rose by 13 percent over the period builds the capacity required for continued sustainable growth and opportunities for achieving ambitious objectives.28 October 2021, 8.00 a.m.     · Rental income rose by 10 percent to SEK 1,027.3 million (937.5). · The net operating surplus increased by 9 percent to SEK 821.3 million (753.1). · Profit from property management rose by 13 percent to SEK 610.9 million (542.5). · Profit for the period increased to SEK 1,614.7 million (805.1),

Invitation to John Mattson’s presentation of the interim report Q3 2021 on 11 November at 10:00 am (CET)

Invitation by John Mattson to the teleconference and webcast on Thursday 11 November at 10:00 a.m. (CET) being held in conjunction with the publication of the company’s interim report for January-September 2021 at 8:00 a.m. (CET) the same date.Investors, asset managers, equity analysts, the press and other stakeholders are invited to participate in the conference, where CEO Siv Malmgren and CFO Maria Sidén will present and comment on the period and result for Q3 2021. No advance notice of attendance is required. Following the presentation, it will be possible to ask questions. The

The shares in DNB Bank ASA will be quoted ex-dividend today

The shares in DNB Bank ASA will be quoted ex-dividend on 28 October 2021. A dividend of NOK 9 per share will be distributed on 5 November 2021 to registered shareholders as at 27 October 2021. For further information, please contact: Rune Helland, head of Investor Relations, tel: +47 977 13 250 This information is subject to the disclosure requirements according to Section 5-12 of the Norwegian Securities Trading Act.

Electrolux Professional AB interim report Q3 2021

Third quarter, July–September 2021· Net sales amounted to SEK 1,935m (1,748). Sales increased by 10.7%. Currency contributed negatively by 2.1%. Organically sales increased by 12.8%. Last year the quarter was more impacted by the pandemic than this year. · EBITA amounted to SEK 199m (96), corresponding to a margin of 10.3% (5.5). Last year the quarter included items affecting comparability of SEK –77m. · Operating income amounted to SEK 183m (81), corresponding to a margin of 9.5% (4.6). Last year the quarter included items affecting comparability of SEK –77m. · Operating cash flow

Welcome to Essity’s virtual Capital Markets Day November 3, 2021

As a leading innovative, digital and sustainable hygiene and health company, Essity will describe the company’s strategy and continued transformation journey, as well as its work to achieve the Group’s goal of profitable growth, net zero emissions by 2050 and improved well-being for people across the globe. The Capital Markets Day will be livestreamed from Essity's headquarters in Stockholm where the company's management team will present the following:Agenda November 3, 2021, kl 14.00-17.00 CET Breaking Barriers to Well-being and Delivering Profitable Growth  · Essity’s

Interim report for Q3 2021

Capital injection initiates a new phase of accelerated expansionThird quarter (July-September 2021) · Revenues amounted to SEK 45.2 (34.1) million, an increase of 32%. Adjusted for currency effects revenues increased by 36%. · EBITDA amounted to SEK 1.2 (-3.1) million with an EBITDA margin of 3% (-9%). · Operating profit amounted to SEK -10.7 (-14.3) million. · Net loss for the period amounted to SEK -10.8 (-16.1) million. Earnings per share amounted to SEK -0.31 (-0.48). · Cash flow from operating activities amounted to SEK 14.3 (-3.3) million, corresponding to SEK 0.41 (-

Citycon’s Financial Reporting Schedule and AGM in 2022

CITYCON OYJ   Stock Exchange Release   28 October 2021 at 09:00 hrsCitycon Oyj’s schedule of the financial reporting in 2022 is the following:  Year 2021 full-year Financial  Report, Financial Statements Thursday 17 February 2022 at about 9:00 a.m. and the Report by the Board ofDirectors  Year 2022 three-month Interim Friday 6 May 2022 at about 9:00 a.m. Report  Year 2022 six-month Half-Yearly Wednesday 13 July 2022 at about 9:00 a.m. Report Year 2022 nine-month Interim Thursday 10 November 2022 at about 9:00 a.m. Report  Citycon Oyj’s Annual General

Citycon Oyj´s Interim Report for 1 January-30 September 2021: Continued strong operational and capital recycling performance

Citycon Oyj   Interim Report   28 October 2021 at 09:00 hrs- Net rental income in Q3/2021 was 51.3 MEUR and increased by +0.4% compared to Q3/2020 on like-for-like basis.- Q3/2021 is the third consecutive quarter with quarter over quarter net rental income growth while the net rental income is close to pre-covid levels.- The disposal of Columbus, a non-core asset, at gross pricing of 106.2 MEUR vs. valuation of 96.3 MEUR in Q4/2020. Consider to use some of the proceeds to repurchase shares.- Rent collection for YTD stands currently at 96 %, Q3/2021 currently at 96% and Q2/2021 at 97%

ETTEPLAN Q3 2021: Good growth continued

ETTEPLAN OYJ Interim Report October 28, 2021, at 9:00 a.m. ETTEPLAN Q3 2021: Good growth continued Key points July-September 2021              · The Group’s revenue grew by 21.1 per cent and was EUR 66.9 million (7-9/2020: EUR 55.2 million). At comparable exchange rates, revenue increased by 20.9 per cent. · Operating profit (EBITA) improved by 9.2 per cent and was EUR 5.7 (5.2) million, or 8.5 (9.5) per cent of revenue. · Operating profit (EBIT) improved by 7.6 per cent and was EUR 4.6 (4.3) million, or 6.9 (7.7) per cent of revenue. · Operating cash flow was EUR 0.2 (0.

German network operator GASCADE Gastransport GmbH has chosen Smartoptics’ open line system for multiservice Data Center Interconnect

Oslo, Norway – October 28, 2021 – Smartoptics, a leading provider of optical networking solutions, today announces that German gas transport company GASCADE Gastransport GmbH, has chosen Smartoptics’ open line system for multiservice Data Center Interconnect (DCI). The new solution is based on Smartoptics’ DCP-M40-PAM4-ZR  and transports 10G, 40G as well as 8G and 16G Fiber Channel (FC) traffic over separate DWDM channels.GASCADE Gastransport GmbH operates one of the largest natural gas infrastructures in Germany. The vast network of

Terrafame’s net sales increased in January–September 2021 to EUR 261.7 million – A Memorandum of Understanding with Renault on battery chemicals deliveries in October

MEDIA RELEASE (The financial information presented about Terrafame Ltd in this bulletin consists of unaudited FAS figures. The figures in brackets refer to the corresponding period of the previous year unless otherwise stated.) July–September 2021 in brief · The battery chemicals plant started deliveries to customers. · Nickel production was 6,542 (4,679) tonnes, representing an increase of 39.8% year-on-year. Zinc production was 13,583 (10,134) tonnes, with an increase of 34.0% year-on-year. The low production figures in the comparison period were due to a long maintenance

Terveystalo Group Interim Report 1 January - 30 September 2021: Revenue growth driven by strong, broad-based demand

Terveystalo Plc, Interim Report, 28 October 2021 at 9:00 EEST This release is a summary of Terveystalo's Interim Report 1 January – 30 September 2021. The full release is attached to this stock exchange release and is available on our website at: https://www.terveystalo.com/en/investors/Financial-information/. July–September 2021 in brief · Revenue increased by 13.7 percent year-on-year to EUR 273.1 (240.2) million. · Adjusted[2)] earnings before interest, taxes, and amortization (EBITA) increased by 1.9 percent to EUR 31.5 (30.9) million, representing 11.5 (12.9) percent of

There are no items matching the current filter
There are no more items matching the current filter
Back to top